Migraine therapeutics differentially modulate the CGRP pathway

BACKGROUND: The clinical efficacy of migraine therapeutic agents directed towards the calcitonin-gene related peptide (CGRP) pathway has confirmed the key role of this axis in migraine pathogenesis. Three antibodies against CGRP – fremanezumab, galcanezumab and eptinezumab – and one antibody against...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhakta, Minoti, Vuong, Trang, Taura, Tetsuya, Wilson, David S, Stratton, Jennifer R, Mackenzie, Kimberly D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054164/
https://www.ncbi.nlm.nih.gov/pubmed/33626922
http://dx.doi.org/10.1177/0333102420983282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054164/
https://www.ncbi.nlm.nih.gov/pubmed/33626922
http://dx.doi.org/10.1177/0333102420983282

Ejemplares similares